NeuroMetrix Inc (NURO)
3.65
+0.08
(+2.24%)
USD |
NASDAQ |
Apr 18, 16:00
3.60
-0.05
(-1.37%)
After-Hours: 20:00
NeuroMetrix SG&A Expense (Quarterly): 1.973M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.973M |
September 30, 2023 | 2.15M |
June 30, 2023 | 1.989M |
March 31, 2023 | 2.209M |
December 31, 2022 | 1.548M |
September 30, 2022 | 1.912M |
June 30, 2022 | 1.747M |
March 31, 2022 | 2.045M |
December 31, 2021 | 1.250M |
September 30, 2021 | 1.408M |
June 30, 2021 | 1.546M |
March 31, 2021 | 1.406M |
December 31, 2020 | 1.116M |
September 30, 2020 | 1.104M |
June 30, 2020 | 1.058M |
March 31, 2020 | 1.676M |
December 31, 2019 | 1.984M |
September 30, 2019 | 2.111M |
June 30, 2019 | 2.938M |
March 31, 2019 | 3.645M |
December 31, 2018 | 3.510M |
September 30, 2018 | 3.350M |
June 30, 2018 | 3.372M |
March 31, 2018 | 4.309M |
December 31, 2017 | 4.080M |
Date | Value |
---|---|
September 30, 2017 | 4.178M |
June 30, 2017 | 4.165M |
March 31, 2017 | 4.020M |
December 31, 2016 | 3.646M |
September 30, 2016 | 4.125M |
June 30, 2016 | 4.125M |
March 31, 2016 | 3.832M |
December 31, 2015 | 3.390M |
September 30, 2015 | 3.352M |
June 30, 2015 | 2.987M |
March 31, 2015 | 3.002M |
December 31, 2014 | 2.354M |
September 30, 2014 | 1.848M |
June 30, 2014 | 1.843M |
March 31, 2014 | 1.593M |
December 31, 2013 | 1.524M |
September 30, 2013 | 1.595M |
June 30, 2013 | 1.872M |
March 31, 2013 | 2.013M |
December 31, 2012 | 2.156M |
September 30, 2012 | 2.604M |
June 30, 2012 | 2.978M |
March 31, 2012 | 2.725M |
December 31, 2011 | 2.752M |
September 30, 2011 | 3.010M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.058M
Minimum
Jun 2020
2.938M
Maximum
Jun 2019
1.746M
Average
1.747M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
Teleflex Inc | 260.65M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |